Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Long-Term Investments (2016 - 2021)

Fortress Biotech (FBIO) has 8 years of Long-Term Investments data on record, last reported at $56.9 million in Q3 2021.

  • For Q3 2021, Long-Term Investments rose 385.03% year-over-year to $56.9 million; the TTM value through Sep 2021 reached $56.9 million, up 385.03%, while the annual FY2020 figure was $17.6 million, 57.57% up from the prior year.
  • Long-Term Investments reached $56.9 million in Q3 2021 per FBIO's latest filing, up from $48.5 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $56.9 million in Q3 2021 and bottomed at $903000.0 in Q2 2017.
  • Average Long-Term Investments over 5 years is $13.4 million, with a median of $11.1 million recorded in 2019.
  • Peak YoY movement for Long-Term Investments: tumbled 41.03% in 2017, then soared 769.18% in 2019.
  • A 5-year view of Long-Term Investments shows it stood at $1.4 million in 2017, then skyrocketed by 380.22% to $6.7 million in 2018, then surged by 67.01% to $11.1 million in 2019, then soared by 57.57% to $17.6 million in 2020, then soared by 223.69% to $56.9 million in 2021.
  • Per Business Quant database, its latest 3 readings for Long-Term Investments were $56.9 million in Q3 2021, $48.5 million in Q2 2021, and $23.5 million in Q1 2021.